文献速递妇科生殖医学

多囊卵巢综合征中抑郁、症状体验与生活质量之间的关系

Association among depression, symptom experience, and quality of life in polycystic ovary syndrome.
PubMed 文献 · Am J Obstet Gynecol · 2018-06-30

本研究为多中心随机临床试验(多囊卵巢综合征妊娠研究II,NCT00719186)的二次分析,纳入732名18-40岁、符合修订鹿特丹标准的多囊卵巢综合征女性,比较抑郁与非抑郁者的生活质量。64人(8.4%)符合抑郁标准,抑郁者在情绪、体毛、体重、月经问题和不孕各领域生活质量均低于非抑郁者,控制年龄、体重指数、多毛评分和不孕时长后仍存在。

要点

  • 抑郁者生活质量各领域评分均低于非抑郁者,总体评分为2.8 vs 3.9。
  • 控制体重指数、多毛评分和不孕时长后,抑郁相关的生活质量下降仍存在。
  • 作者认为抑郁可能影响多囊卵巢综合征症状的体验,主客观指标明显不一致时应考虑抑郁。

核心结论

  • 抑郁与多囊卵巢综合征症状相关的生活质量下降有关,且这种下降不能由体重指数、多毛评分和不孕时长等客观指标解释。
  • 作者认为抑郁可能影响多囊卵巢综合征症状的体验,当主观与客观指标明显不一致时应考虑抑郁。

研究设计与样本

  • 多中心随机临床试验(多囊卵巢综合征妊娠研究II,NCT00719186)的二次分析,该试验比较枸橼酸氯米芬与来曲唑治疗不孕。
  • 纳入732名18-40岁、符合修订鹿特丹标准的多囊卵巢综合征女性。
  • 使用经验证的多囊卵巢综合征健康相关生活质量问卷自评,涵盖情绪、体毛、体重、月经问题和不孕领域,评分1-7分,分值越低生活质量越差。
  • 采用初级保健精神障碍评估患者健康问卷评估抑郁,比较抑郁与非抑郁女性的生活质量评分。
  • 多变量线性回归分析抑郁与生活质量评分的关联,控制年龄、体重指数、多毛评分和不孕时长。

主要发现

  • 64名女性(8.4%)符合抑郁标准。
  • 抑郁者各领域生活质量均低于非抑郁者:情绪(3.1 vs 4.6,P < .001)、体毛(3.5 vs 4.2,P = .002)、体重(2.0 vs 3.5,P < .001)、月经问题(3.3 vs 4.1,P < .001)、不孕(1.9 vs 3.0,P < .001)。
  • 抑郁者总体生活质量评分低于非抑郁者(2.8 vs 3.9,P < .001)。
  • 控制年龄、体重指数、多毛评分和不孕时长后,抑郁者各领域生活质量下降仍存在。

临床怎么用

  • 作者认为抑郁可能影响多囊卵巢综合征症状的体验,当主观与客观指标明显不一致时应考虑抑郁。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical stigmata of polycystic ovary syndrome include hirsutism, obesity, menstrual disturbances, and infertility. These symptoms impair health-related quality of life. Depression is also common. The relationship among depression, symptom self-perception, and quality of life in polycystic ovary syndrome is poorly understood. OBJECTIVE: We sought to investigate the relationship between health-related quality of life and depression in women with polycystic ovary syndrome. STUDY DESIGN: We conducted a secondary analysis of a multicenter, randomized clinical trial (Pregnancy in Polycystic Ovary Syndrome II, NCT00719186) comparing clomiphene citrate vs letrozole in the treatment of infertility. Subjects included 732 women ages 18-40 years with polycystic ovary syndrome by modified Rotterdam criteria. The validated Polycystic Ovary Syndrome Health-Related Quality of Life survey was self-administered, assessing the following domains: emotions, body hair, body weight, menstrual problems, and infertility; scores range from 1-7, with lower numbers indicating poorer quality of life. Depression was evaluated via the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire. Quality-of-life scores were compared between depressed and nondepressed women. Multivariate linear regression models analyzed the association between depression and quality-of-life scores, controlling for age, body mass index, hirsutism score, and duration of infertility. RESULTS: In all, 64 women (8.4%) met criteria for depression. Depressed women reported reduced quality of life in all domains compared to nondepressed women: mood (3.1 vs 4.6, P < .001), body hair (3.5 vs 4.2, P = .002), weight (2.0 vs 3.5, P < .001), menstrual problems (3.3 vs 4.1, P < .001), and infertility (1.9 vs 3.0, P < .001). Global quality-of-life score was reduced in depressed women (2.8 vs 3.9, P < .001). Impairments in quality of life in depressed women persisted in all domains after controlling for objective parameters including age, body mass index, hirsutism score, and infertility duration. CONCLUSION: Depression is associated with reduced quality of life related to polycystic ovary syndrome symptoms. Disturbances in health-related quality of life in depressed women are not explained by objective measures including body mass index, hirsutism scores, and duration of infertility. Depression may color the experience of polycystic ovary syndrome symptoms and should be considered when there is significant discordance between subjective and objective measures in women with polycystic ovary syndrome.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Greenwood EA, Pasch LA, Cedars MI, et al. Association among depression, symptom experience, and quality of life in polycystic ovary syndrome. Am J Obstet Gynecol. 2018. PMID: 29969586. doi:10.1016/j.ajog.2018.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。